LEP and metabolic syndrome: They showed that VAT associated with an adverse metabolic, dyslipidemic, and atherogenic obesity phenotype, whereas SAT associated with a more benign phenotype, characterized by modest associations with inflammatory biomarkers and leptin, but no independent association with dyslipidemia, insulin resistance, or atherosclerosis in individuals with obesity.